ATYR (aTyr Pharma) Tax Rate %: 0.00% (As of Mar. 2026)

What is aTyr Pharma Tax Rate %?

aTyr Pharma ATYR -8.24% 14 Tax Rate % is 0.00% as of Mar. 2026. GuruFocus rates ATYR with a GF Score™ of 14/100 and a GF Value™ of $0.46 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. aTyr Pharma's Tax Expense for the three months ended in Mar. 2026 was $0.00 Mil. aTyr Pharma's Pre-Tax Income for the three months ended in Mar. 2026 was $-10.79 Mil. Therefore, aTyr Pharma's Tax Rate % for the quarter that ended in Mar. 2026 was 0.00%.

aTyr Pharma Tax Rate % Related Terms

aTyr Pharma Tax Rate % Historical Data

* Premium members only.

The historical data trend for aTyr Pharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aTyr Pharma Tax Rate % Chart

aTyr Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Tax Rate %

Get a 7-Day Free Trial

0.00

aTyr Pharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Tax Rate %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

14GF Score

aTyr Pharma Inc ATYR

Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

aTyr Pharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

aTyr Pharma's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2025 )	/	Pre-Tax Income (A: Dec. 2025 )
	=	0	/	-74.123
	=	0.00 %

aTyr Pharma's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2026 )	/	Pre-Tax Income (Q: Mar. 2026 )
	=	0	/	-10.792
	=	0.00 %

Frequently Asked Questions Learn more about Tax Rate % →

What does a Tax Rate % of 0.00% mean?

aTyr Pharma (ATYR) has a Tax Rate % of 0.00% as of Mar. 2026.

Is aTyr Pharma's Tax Rate % too high?

aTyr Pharma's current Tax Rate % is 0.00%. Overall, aTyr Pharma has a GF Score™ of 14/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does aTyr Pharma's Tax Rate % compare to DWTX and CNTX?

aTyr Pharma's Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Tax Rate % for a Biotechnology company?

A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Tax Rate % mean?

A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. aTyr Pharma's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is aTyr Pharma stock overvalued right now?

Based on GuruFocus' analysis, aTyr Pharma (ATYR) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.46, compared to a current price of $0.59 — trading 28.3% above its estimated fair value. The current Tax Rate % is 0.00%. aTyr Pharma's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Tax Rate % calculated?

Tax Rate % is calculated from a company's financial statements. For aTyr Pharma (ATYR), the current Tax Rate % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aTyr Pharma (ATYR) Overvalued in 2026?

Based on GuruFocus' analysis, aTyr Pharma stock appears to be overvalued. The current stock price of $0.59 is trading 28.3% above its estimated GF Value™ of $0.46. GuruFocus considers aTyr Pharma to be Modestly Overvalued.

Key valuation signals for ATYR:

Tax Rate %: 0.00%
GF Value™: $0.46 vs. price of $0.59 (28.3% above fair value)
GF Score™: 14/100 with 4 warning signs

No single metric tells the full story. See the ATYR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aTyr Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies DWTX CNTX INKT BOLD FLNA IBO TIL XLO LTRN PDSB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 471A:Germany

Address 10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121

Website https://www.atyrpharma.com

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

14GF Score

Get the complete analysis for ATYR

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59

Price

$0.46

GF Value

View ATYR Analysis

See Tax Rate % data for all stocks →